3416733 SCID severe combined immunodeficiency 4575 3416863 scid severe combined immune deficiency 42 3416864 scid severe combined immune deficiency mutation 3 3416872 scid severely immunodeficient NOD.Cg-Prkdc 2 3416852 scid stocks of immunodeficient Prkdc 2 3416840 scid studies in NOD.Cg-Prkdc 2 3416873 scid cByJ.scid 1 3416869 scid donor-patient-specific NOD.Cg-Prkdc 1 3416870 scid iPS cells, injected into NOD.Cg-Prkdc 1 3416871 scid sc chimeras indicated that APCs of recipient 1 3416876 scid SC through the intrafemoral route into immunodeficient NOD.Cg-Prkdc 1 3416877 scid SCID mice bearing the Prkdc 1 3416865 scid second case, which involved NOD.Cg-Prkdc 1 3416866 scid seminal plasma or to control medium before transfer to Prkdc 1 3416867 scid sensitivity of immunodeficient SBSs NOD.CB17-Prkdc 1 3416868 scid septicaemia caused by infection with Aerococcus viridans in immunodeficient NOD/LtSz-Prkdc 1 3416862 scid severe combined immunodeficiency (prkdc(scid)) mutation 1 3416859 scid severe combined immunodeficiency syndrome 1 3416874 scid Severe Combined Immunodeficiency-mice 1 3416860 scid severe combined immunodeficient mutation 1 3416861 scid severe immunodeficiency 1 3416858 scid severely immunodeficient 1 3416854 scid severely impaired due to a recessive mutation 1 3416875 scid SHP-1-deficient (Shp-1(-/-)) mice and NOD.NOR-Idd13.Prkdc 1 3416855 scid similar immunosuppressive effect of JP-3-110 and MPA in humanized NOD.Cg-Prkdc 1 3416856 scid sites in immunodeficient NOD.Cg-Prkdc 1 3416857 scid skin-derived T cell cultures, which were transferred to NOD.Cg-Prkd 1 3416853 scid specimens were initially established in NOD.CB17-Prkdc 1 3416843 scid spleen of optimally conditioned Nod/LtSz-Prkdc 1 3416844 scid stably transfected cells were injected intravenously into NOD.Cg-Prkdc 1 3416849 scid stem cell engrafted virus-infected NOD.Cg-Prkdc 1 3416850 scid stem cell line from NOD.Cg-Prkdc 1 3416851 scid stem cells, including NOD.Cg-Prkdc 1 3416845 scid strain code 394; NOD.CB17- Prkdc 1 3416847 scid strain, and NOD/LtSz-Prkdc 1 3416846 scid strain, C.B-17/Icr-Prkdc 1 3416848 scid strain, namely NOD.Cg-Prkdc 1 3416834 scid strains BALB/cJ, C.B-17-Prkdc 1 3416835 scid strains of NOD.CB17-Prkdc 1 3416836 scid strains with combined Prkdc 1 3416839 scid strategy was subsequently evaluated in the NOD.Cg-Prkdc 1 3416841 scid studies of mouse parvovirus 1 in BALB/c and C.B-17/Icr-Prkdc 1 3416842 scid subcutaneous injection into nonobese diabeteic.Cg-Prkdc 1 3416837 scid successfully rescued C.B-17/Icr-Prkdc 1 3416838 scid support lymphohaematopoietic cell engraftment with that achieved in radiosensitive NOD.CB17-Prkdc 1 3416833 scid surgically implanted into C.B.-Igh-1(b)/IcrTac-Prkdc 1